Dow Chemical Company’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Dow Chemical Company’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-33,427	Closed	-$3.53M	–	7
2020 Q3	$3.53M	Buy	+33,427	New	+$3.52M	1.39%	6
2020 Q1	–	Sell	-87,568	Closed	-$8.92M	–	13
2019 Q4	$8.92M	Buy	87,568 +80,350	+1,113%	+$7.73M	1.96%	9
2019 Q3	$651K	Sell	7,218 -25,032	-78%	-$2.29M	0.15%	16
2019 Q2	$2.99M	Sell	32,250 -18,366	-36%	-$1.65M	0.46%	14
2019 Q1	$4.64M	Sell	50,616 -20,743	-29%	-$1.87M	0.7%	8
2018 Q4	$6.17M	Sell	71,359 -26,901	-27%	-$2.43M	0.98%	9
2018 Q3	$9.35M	Buy	98,260 +28,260	+40%	+$2.55M	1.28%	7
2018 Q2	$5.84M	Buy	70,000 +31,244	+81%	+$2.59M	2.1%	10
2018 Q1	$3.15M	Buy	38,756 +13,756	+55%	+$1.17M	1.15%	14
2017 Q4	$2.07M	Sell	25,000 -37,041	-60%	-$3.05M	0.5%	16
2017 Q3	$5.07M	Sell	62,041 -21,282	-26%	-$1.71M	1.26%	12
2017 Q2	$6.6M	Sell	83,323 -337,583	-80%	-$25.7M	0.69%	15
2017 Q1	$31.3M	Sell	420,906 -133,701	-24%	-$9.75M	3.51%	9
2016 Q4	$40M	Hold	554,607	–	–	4.13%	8
2016 Q3	$40M	Buy	554,607 +45,586	+9%	+$3.36M	3.91%	8
2016 Q2	$36.5M	Buy	509,021 +141,269	+38%	+$9.95M	3.75%	8
2016 Q1	$24.9M	Buy	367,752 +19,051	+5%	+$1.28M	2.41%	12
2015 Q4	$25.1M	Buy	348,701 +289,134	+485%	+$20.4M	2.42%	13
2015 Q3	$3.94M	Sell	59,567 -199,855	-77%	-$14.6M	0.33%	32
2015 Q2	$19.3M	Buy	259,422 +36,279	+16%	+$2.69M	1.77%	10
2015 Q1	$16.2M	Sell	223,143 -88,168	-28%	-$6.29M	1.43%	11
2014 Q4	$21.3M	Buy	311,311 +156,490	+101%	+$10.5M	1.91%	9
2014 Q3	$9.89M	Sell	154,821 -34,861	-18%	-$2.18M	0.87%	13
2014 Q2	$11.5M	Buy	189,682 +25,539	+16%	+$1.5M	0.97%	14
2014 Q1	$9.6M	Sell	164,143 -20,678	-11%	-$1.19M	0.79%	14
2013 Q4	$10.2M	Hold	184,821	–	–	0.85%	10
2013 Q3	$9.35M	Hold	184,821	–	–	0.78%	10
2013 Q2	$8.8M	Buy	+184,821	New	+$8.85M	0.78%	9

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NLI

Nippon Life Insurance Tokyo, Japan $6.04B AUM 4.21% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dow Chemical Company's XLV Position: Q4 2020 in Review

Dow Chemical Company sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q4 2020, closing a stake of 33,427 shares — an estimated $3.53M sold.

Dow Chemical Company first reported a position in XLV in Q2 2013 and held it in 28 quarters. The position peaked at $40M in Q4 2016. 1,167 funds tracked by Wall St. Rank hold XLV as of Q4 2020.

Dow Chemical Company reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q4 2020 after selling out during the quarter.
Dow Chemical Company sold 33,427 State Street Health Care Select Sector SPDR ETF shares in Q4 2020, an estimated $3.53M.
Dow Chemical Company first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and held it in 28 quarters.
Dow Chemical Company's State Street Health Care Select Sector SPDR ETF position peaked at $40M in Q4 2016.
1,167 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2020.

Based on Dow Chemical Company's 13F filing for Q4 2020, filed 12 Feb 2021.